A recent study from the Archives of the Turkish Society of Cardiology suggests that measuring CT attenuation could help improve the diagnosis of malignant pericardial effusion (MPE), especially when it is combined with clinical and lab data. MPE, which often shows up as cardiac tamponade, is a serious condition with a poor outlook. While analyzing pericardial fluid under a microscope remains the diagnostic gold standard, it is not always sensitive enough to detect all cases. That is where CT scans may offer added value.
Researchers looked at 102 patients who had both chest CT scans and pericardiocentesis procedures. Based on pathology results, the researchers grouped the patients into malignant and non-malignant effusion categories. They then measured CT attenuation at three specific levels of the heart using Hounsfield Units (HU) to see if there was a clear difference.
Out of the total, 44 patients (about 43%) were diagnosed with MPE. These patients showed much higher CT attenuation values compared to those with non-malignant effusions; median values were 24.4 HU for MPE vs. 9.3 HU for the rest. Even when researchers adjusted for other factors, CT attenuation remained a strong independent predictor. The model that included CT data (Model 2) outperformed the one without it, with the ROC curve improving from 0.860 to 0.893.
Using a cut-off value of 16.45 HU, the scan could predict MPE with 88.2% sensitivity and 78.3% specificity.